母婴同室早发感染高危新生儿临床管理专家共识

2021-08-16 中国医师协会新生儿科医师分会 中华围产医学杂志. 2021,24(08)

新生儿早发感染(early-onset neonatal infection,EONI)是威胁新生儿生命健康的严重疾病,多种产科因素可增加EONI风险,如何管理EONI高危新生儿,既能有效预防和治疗E

中文标题:

母婴同室早发感染高危新生儿临床管理专家共识

发布日期:

2021-08-16

简要介绍:

新生儿早发感染(early-onset neonatal infection,EONI)是威胁新生儿生命健康的严重疾病,多种产科因素可增加EONI风险,如何管理EONI高危新生儿,既能有效预防和治疗EONI,又能尽量减少抗生素应用,是产科和新生儿科面临的巨大挑战。中国妇幼保健协会新生儿保健专业委员会和中国医师协会新生儿科医师分会组织成立专家组,通过文献检索和分析讨论形成具有证据等级的共识草案,并采用德尔菲法对各条共识进行匿名专家调查反馈及投票,制定了此共识。共识强调了产科和儿科间信息沟通和密切临床观察对EONI早期识别和防治的重要性。同时建议所有EONI高危新生儿应留院严密观察至少48 h;若新生儿出现感染症状,或新生儿无感染症状但存在母亲绒毛膜羊膜炎或侵袭性细菌感染,或同时存在≥2项高危因素包括母亲产时发热≥38 ℃、B族链球菌定植、胎膜早破≥18 h以及自发性早产时,建议转新生儿科进一步评价并预防性使用抗生素。 
 

相关资料下载:
[AttachmentFileName(sort=1, fileName=母婴同室早发感染高危新生儿临床管理专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=c9b5f1c002195a53, title=母婴同室早发感染高危新生儿临床管理专家共识, enTitle=, guiderFrom=中华围产医学杂志. 2021,24(08), authorId=0, author=, summary=新生儿早发感染(early-onset neonatal infection,EONI)是威胁新生儿生命健康的严重疾病,多种产科因素可增加EONI风险,如何管理EONI高危新生儿,既能有效预防和治疗E, cover=https://img.medsci.cn/2021929/1632845999120_2020535.jpg, journalId=0, articlesId=null, associationId=928, associationName=中国医师协会新生儿科医师分会, associationIntro=null, copyright=0, guiderPublishedTime=Mon Aug 16 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="row"><span id="ChDivSummary" class="abstract-text" style="color: #666666;">新生儿早发感染(early-onset neonatal infection,EONI)是威胁新生儿生命健康的严重疾病,多种产科因素可增加EONI风险,如何管理EONI高危新生儿,既能有效预防和治疗EONI,又能尽量减少抗生素应用,是产科和新生儿科面临的巨大挑战。中国妇幼保健协会新生儿保健专业委员会和中国医师协会新生儿科医师分会组织成立专家组,通过文献检索和分析讨论形成具有证据等级的共识草案,并采用德尔菲法对各条共识进行匿名专家调查反馈及投票,制定了此共识。共识强调了产科和儿科间信息沟通和密切临床观察对EONI早期识别和防治的重要性。同时建议所有EONI高危新生儿应留院严密观察至少48 h;若新生儿出现感染症状,或新生儿无感染症状但存在母亲绒毛膜羊膜炎或侵袭性细菌感染,或同时存在&ge;2项高危因素包括母亲产时发热&ge;38 ℃、B族链球菌定植、胎膜早破&ge;18 h以及自发性早产时,建议转新生儿科进一步评价并预防性使用抗生素。&nbsp;</span></div> <div class="row">&nbsp;</div>, tagList=[TagDto(tagId=2173, tagName=新生儿)], categoryList=[CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2173, guiderKeyword=新生儿, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4304, appHits=111, showAppHits=0, pcHits=1283, showPcHits=4191, likes=1, shares=29, comments=4, approvalStatus=1, publishedTime=Wed Sep 29 00:47:26 CST 2021, publishedTimeString=2021-08-16, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Sep 29 00:20:10 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Thu Jan 04 05:56:41 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=母婴同室早发感染高危新生儿临床管理专家共识.pdf)])
母婴同室早发感染高危新生儿临床管理专家共识.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1200332, encodeId=a5bf1200332a7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/37606e0e773b4cc0b4aac9113ec9e322/bda806cd97884aa4ae43681554a22d0c.jpg, createdBy=e8aa6417357, createdName=乐乐笑笑, createdTime=Mon Mar 07 20:34:22 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061746, encodeId=2eee1061e4632, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45065319743, createdName=148a6ab0m96暂无昵称, createdTime=Tue Oct 19 09:46:40 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057979, encodeId=0ae3105e9796b, content=受益匪浅,谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:06:30 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
    2022-03-07 乐乐笑笑

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1200332, encodeId=a5bf1200332a7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/37606e0e773b4cc0b4aac9113ec9e322/bda806cd97884aa4ae43681554a22d0c.jpg, createdBy=e8aa6417357, createdName=乐乐笑笑, createdTime=Mon Mar 07 20:34:22 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061746, encodeId=2eee1061e4632, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45065319743, createdName=148a6ab0m96暂无昵称, createdTime=Tue Oct 19 09:46:40 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057979, encodeId=0ae3105e9796b, content=受益匪浅,谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:06:30 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
    2021-10-19 148a6ab0m96暂无昵称

    受益匪浅,谢谢分享

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1200332, encodeId=a5bf1200332a7, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/37606e0e773b4cc0b4aac9113ec9e322/bda806cd97884aa4ae43681554a22d0c.jpg, createdBy=e8aa6417357, createdName=乐乐笑笑, createdTime=Mon Mar 07 20:34:22 CST 2022, time=2022-03-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061746, encodeId=2eee1061e4632, content=受益匪浅,谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45065319743, createdName=148a6ab0m96暂无昵称, createdTime=Tue Oct 19 09:46:40 CST 2021, time=2021-10-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057979, encodeId=0ae3105e9796b, content=受益匪浅,谢谢分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bb85598371, createdName=henghengbobo, createdTime=Wed Oct 06 00:06:30 CST 2021, time=2021-10-06, status=1, ipAttribution=)]
    2021-10-06 henghengbobo

    受益匪浅,谢谢分享!

    0